TECX Tectonic Therapeutic Inc.

Price (delayed)

$28.98

Market cap

$546.83M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.46

Enterprise value

$314.08M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 4

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.

Highlights
The EPS has grown by 27% year-on-year but it has declined by 10% since the previous quarter
TECX's debt has surged by 76% year-on-year
TECX's net income is down by 42% year-on-year and by 13% since the previous quarter

Key stats

What are the main financial stats of TECX

TECX stock price

How has the Tectonic Therapeutic stock price performed over time
Intraday
1.97%
1 week
-2.69%
1 month
-2.26%
1 year
27.89%
YTD
38.93%
QTD
-6.24%

Financial performance

How have Tectonic Therapeutic's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$93.04M
Net income
-$83.49M
Gross margin
N/A
Net margin
N/A
TECX's operating income is down by 47% year-on-year and by 11% since the previous quarter
TECX's net income is down by 42% year-on-year and by 13% since the previous quarter

Price vs fundamentals

How does TECX's price correlate with its fundamentals

Growth

What is Tectonic Therapeutic's growth rate over time

Valuation

What is Tectonic Therapeutic stock price valuation
P/E
N/A
P/B
2.36
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 27% year-on-year but it has declined by 10% since the previous quarter
TECX's price to book (P/B) is 93% more than its 5-year quarterly average of 1.2 and 45% more than its last 4 quarters average of 1.6
Tectonic Therapeutic's equity has decreased by 23% YoY and by 8% from the previous quarter

Efficiency

How efficient is Tectonic Therapeutic business performance
The return on assets has declined by 20% since the previous quarter and by 9% year-on-year
Tectonic Therapeutic's ROE has decreased by 20% from the previous quarter and by 4.5% YoY

Dividends

What is TECX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TECX.

Financial health

How did Tectonic Therapeutic financials performed over time
The total liabilities has soared by 66% QoQ and by 17% YoY
Tectonic Therapeutic's quick ratio has decreased by 31% from the previous quarter and by 19% YoY
TECX's debt is 98% smaller than its equity
The debt to equity has soared by 100% QoQ and by 100% YoY
TECX's debt has surged by 76% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.